Olyth
Home
About
Terms
Privacy
Oculis Holding AG Warrants (OCSAW) Stock Price, Chart & News | Olyth
OCSAW
Oculis Holding AG Warrants
$4.07
-$0.15 (-3.55%)
Today
Chart data unavailable
Key Statistics
Market cap
—
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.6K
High today
$4.22
Low today
$4.22
Open price
$9.91
Volume
1.6K
52 Week high
$4.22
52 Week low
$4.22
Company Profile
Recent News
Company Profile
No profile description available.
Recent News
GlobeNewswire
6/15/2026
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
GlobeNewswire
6/11/2026
Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026
GlobeNewswire
6/9/2026
Oculis Announces First Patient Randomized in PREDICT-1 Registrational Trial of Licaminlimab, Advancing Precision Medicine in Dry Eye Disease
GlobeNewswire
6/8/2026
Oculis to Present at the 47th Annual Goldman Sachs Global Healthcare Conference
Motley Fool
6/8/2026
Nan Fung Group Sells $4.3 Million in Oculis Shares As Lead Drug Stumbles
Stocktwits
5/29/2026
OCS Stock Drops Over 23% — Eye Drop Trial For Diabetic Vision Loss Misses Target
MT Newswires
5/29/2026
Oculis Holding AG Phase 3 Trial of Potential Eye Drops for Diabetic Patients Fails to Primary Endpoint
GlobeNewswire
5/29/2026
Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema